Biofidelity raises £9.2m for cancer detection tech

Biofidelity has raised a £9.2 million in a Series A round led by BlueYard Capital and backed by investors including Longwall Ventures and Agilent Technologies.

The Cambridge-based HealthTech firm aims to simplify genetic testing using next generation sequencing (NGS). It estimates that 95 per cent of cancer patients are currently excluded from NGS due to high cost, complexity and slow turnaround times.

Biofidelity provides clinically actionable data based on ultra-sensitive detection of the markers recommended in cancer treatment guidelines, helping oncologists prescribe the right cancer drug at the right time.

The company is initially focusing on diagnosis of non-small cell lung cancer, with potential across a broad range of other cancers, as well as applications in the detection of resistance to therapy and disease recurrence.

The investment will be used to accelerate the development and clinical validation of oncology panels for treatment selection and patient monitoring in oncology.

Barnaby Balmforth, chief executive and co-founder of Biofidelity, said: “We are removing the barriers that prevent the vast majority of patients from having access to the high-quality information associated with existing DNA sequencing approaches."

Cameron Frayling, the other co-founder of Biofidelity, added: “With an initial focus on well-established, widely reimbursed markers used in targeted treatment of non-small cell lung cancer, Biofidelity has potential in a broad range of cancers and future applications in routine monitoring of patients for detection of resistance to therapy and disease recurrence.”

    Share Story:

Recent Stories


The future-ready CFO: Driving strategic growth and innovation
This National Technology News webinar sponsored by Sage will explore how CFOs can leverage their unique blend of financial acumen, technological savvy, and strategic mindset to foster cross-functional collaboration and shape overall company direction. Attendees will gain insights into breaking down operational silos, aligning goals across departments like IT, operations, HR, and marketing, and utilising technology to enable real-time data sharing and visibility.

The corporate roadmap to payment excellence: Keeping pace with emerging trends to maximise growth opportunities
In today's rapidly evolving finance and accounting landscape, one of the biggest challenges organisations face is attracting and retaining top talent. As automation and AI revolutionise the profession, finance teams require new skillsets centred on analysis, collaboration, and strategic thinking to drive sustainable competitive advantage.